When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
CAPR - Capricor reports positive data from mid-stage study of CAP-1002 in DMD
Capricor Therapeutics Inc.
Capricor Therapeutics (NASDAQ:CAPR) announces topline results from a Phase 2 clinical trial, HOPE-2, evaluating lead candidate CAP-1002 in patients with advanced Duchenne muscular dystrophy (DMD).
More news on: Capricor Therapeutics, Inc., Healthcare stocks news, Stocks on the move,